Vyxeos liposomal (previously known as Vyxeos) 유럽 연합 - 체코어 - EMA (European Medicines Agency)

vyxeos liposomal (previously known as vyxeos)

jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemie, myeloidní, akutní - antineoplastická činidla - vyxeos lipozomální je indikován k léčbě dospělých pacientů s nově diagnostikovaným, terapie související s akutní myeloidní leukémií (t-aml), nebo aml s myelodysplasie-související změny (aml-mrc).

Namuscla 유럽 연합 - 체코어 - EMA (European Medicines Agency)

namuscla

lupin europe gmbh - mexiletine hydrochloride - myotonické poruchy - kardioterapie - namuscla je indikován k symptomatické léčbě myotonie u dospělých pacientů s non-dystrofické myotonické poruchy.

LysaKare 유럽 연합 - 체코어 - EMA (European Medicines Agency)

lysakare

advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - radiační poranění - detoxifying agents for antineoplastic treatment - lysakare je indikován pro snížení renální záření při peptide-receptor radionuklidové terapii (prrt) s lutecia (177lu) oxodotreotide u dospělých.

Acrescent 유럽 연합 - 체코어 - EMA (European Medicines Agency)

acrescent

h. lundbeck a/s - memantin-hydrochlorid, donepezil-hydrochlorid - alzheimerova choroba - treatment of alzheimers disease.

Stelfonta 유럽 연합 - 체코어 - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - psi - pro léčbu non-resekabilním, non-metastatický (kdo staging) podkožní mastocytů se nachází na nebo distální k lokti, nebo hleznu, a non-resekabilním, non metastazující kožní žírných buněk nádory u psů.

Elzonris 유럽 연합 - 체코어 - EMA (European Medicines Agency)

elzonris

stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastická činidla - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).

Exparel liposomal 유럽 연합 - 체코어 - EMA (European Medicines Agency)

exparel liposomal

pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

Pepaxti 유럽 연합 - 체코어 - EMA (European Medicines Agency)

pepaxti

oncopeptides ab - melphalan flufenamide hydrochloride - mnohočetný myelom - antineoplastická činidla - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Ebvallo 유럽 연합 - 체코어 - EMA (European Medicines Agency)

ebvallo

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

PARACETAMOL/PHENYLEPHRINE HYDROCHLORIDE/ASCORBIC ACID OMEGA PHARMA 300MG/5MG/20MG Prášek pro perorální roztok v sáčku 체코 - 체코어 - SUKL (Státní ústav pro kontrolu léčiv)

paracetamol/phenylephrine hydrochloride/ascorbic acid omega pharma 300mg/5mg/20mg prášek pro perorální roztok v sáčku

omega pharma a.s., brno array - 1064 paracetamol; 1122 fenylefrin-hydrochlorid; 102 kyselina askorbovÁ - prášek pro perorální roztok v sáčku - 300mg/5mg/20mg - paracetamol, kombinace kromĚ psycholeptik